Rabbit monoclonal antibody (RabMAb) demonstrates larger sensitivity with out sacrificing specificity than mouse monoclonal antibody (MMAb). MMAb towards E-cadherin stain is closely utilized in distinguishing ductal carcinoma in situ (DCIS) from lobular carcinoma in situ (LCIS). We aimed to check the E-cadherin stain utilizing RabMAb vs MMAb in distinguishing DCIS from LCIS.
One hundred and seventeen in situ breast carcinomas (55 DCIS, 58 LCIS, and four DCIS and LCIS) have been studied. Sections from a consultant block of every have been stained with RabMAb [EP700Y] and MMAb [36B5]. Scanned photos of stained slides have been in contrast in tandem.
All DCIS instances (59/59) confirmed comparable staining by RabMAb and MMAb. Comparable staining was additionally noticed in all however one case of LCIS (61/62; 98%).
One case of pleomorphic LCIS confirmed principally full, weak to reasonably intense membranous staining with RabMAb and fragmented, weak membranous staining with MMAb.
NFAT Inhibitor |
H-4874.0500 |
Bachem |
0.5mg |
EUR 327.6 |
Description: Sum Formula: C75H118N20O22S; CAS# [249537-73-3] net |
NFAT Inhibitor |
H-4874.1000 |
Bachem |
1.0mg |
EUR 544.8 |
Description: Sum Formula: C75H118N20O22S; CAS# [249537-73-3] net |
pGreenFire1-4x-NFAT (plasmid) |
TR051pa-1 |
SBI |
10 ug |
EUR 943.2 |
|
pGreenFire1-4x-NFAT (virus) |
TR051va-1 |
SBI |
>2 x 10^6 IFUs |
EUR 943.2 |
|
pGreenFire 2.0 NFAT reporter plasmid (pGF2-NFAT-rFluc-T2A-GFP-mPGK-Puro) |
TR451PA-P |
SBI |
10 µg |
EUR 920.4 |
|
pGreenFire 2.0 NFAT reporter virus (pGF2-NFAT-rFluc-T2A-GFP-mPGK-Puro) |
TR451VA-P |
SBI |
>2 x 10^6 IFUs |
EUR 920.4 |
|
NFAT Transcription Factor Regulator-1 |
HY-112778 |
MedChemExpress |
100mg |
EUR 3847.2 |
Mouse NFAT activation molecule 1 (NFAM1) ELISA Kit |
abx255120-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Human NFAT activation molecule 1 (NFAM1) ELISA Kit |
abx520337-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Mouse Nfam1(NFAT activation molecule 1) ELISA Kit |
EM0772 |
FN Test |
96T |
EUR 681.12 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Mus ;Sensitivity: 0.094 ng/ml |
Mouse Nfam1/ NFAT activation molecule 1 ELISA Kit |
E1020Mo |
Sunlong |
1 Kit |
EUR 758.4 |
Human NFAM1/ NFAT activation molecule 1 ELISA Kit |
E1735Hu |
Sunlong |
1 Kit |
EUR 726 |
ELISA kit for Mouse NFAT activation molecule 1 |
EK4618 |
SAB |
96 tests |
EUR 723.6 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Mouse NFAT activation molecule 1 in samples from serum, plasma, tissue homogenates and other biological fluids. |
Human NFAT activation molecule 1, NFAM1 ELISA KIT |
ELI-36505h |
Lifescience Market |
96 Tests |
EUR 988.8 |
Mouse NFAT activation molecule 1, Nfam1 ELISA KIT |
ELI-38266m |
Lifescience Market |
96 Tests |
EUR 1038 |
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody |
20-abx217148 |
Abbexa |
|
|
|
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody |
20-abx301606 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody |
abx235689-100ug |
Abbexa |
100 ug |
EUR 661.2 |
|
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody (HRP) |
20-abx310130 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody (FITC) |
20-abx310131 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
NFAT Activating Protein With ITAM Motif 1 (NFAM1) Antibody (Biotin) |
20-abx310132 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Nfam1 ELISA Kit| Mouse NFAT activation molecule 1 ELISA Kit |
EF013382 |
Lifescience Market |
96 Tests |
EUR 826.8 |
Consistently higher staining high quality was noticed in slides stained by RabMAb vs MMAb. RabMAb and MMAb towards E-cadherin have been diagnostically equal aside from one case the place RabMAb might have led to diagnostic misinterpretation.
However, the not insignificant value financial savings and simpler interpretation utilizing RabMAb might justify the chance of misinterpretation of elevated staining in uncommon instances, largely avertable with correct coaching.